Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Tobias, Tritschler"'
Autor:
Nicholas L. J. Chornenki, Tobias Tritschler, Fabian Stucki, Roupen Odabashian, Jenneke Leentjens, Faizan Khan, Valentina Ly, Deborah M. Siegal
Publikováno v:
Systematic Reviews, Vol 11, Iss 1, Pp 1-7 (2022)
Abstract Background Gastrointestinal (GI) bleeding represents the single most frequent site of anticoagulant-related bleeding. Adverse outcomes after major GI bleeding including mortality are not well characterized and, as a result, may be underappre
Externí odkaz:
https://doaj.org/article/7b2341b739364d7ab5fa06df7ed8b87f
Autor:
Marc Rodger, Grégoire Le Gal, Kednapa Thavorn, Faizan Khan, Tobias Tritschler, Dean Fergusson, Doug Coyle, Sasha van Katwyk
Publikováno v:
BMJ Open, Vol 13, Iss 1 (2023)
Introduction Deciding whether to stop or extend anticoagulant therapy indefinitely after completing at least 3 months of initial treatment for a first unprovoked venous thromboembolism (VTE) remains a challenge for clinicians, patients and policy mak
Externí odkaz:
https://doaj.org/article/9ab5aee24ffd4ed781c19aa767680299
Autor:
Tobias Tritschler, Anuj Patel, Noémie Kraaijpoel, Deepak L. Bhatt, Giuseppe De Luca, Pietro Di Santo, Fausto Feres, Ricardo A. Costa, Benjamin Hibbert, Takaaki Isshiki, Grégoire Le Gal, Lana A. Castellucci
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 7, Pp n/a-n/a (2022)
Abstract Background Assessment of the case‐fatality rate (CFR) of major bleeding on dual antiplatelet therapy (DAPT) may improve balancing risks and benefits of different durations of DAPT following percutaneous coronary intervention (PCI). Objecti
Externí odkaz:
https://doaj.org/article/aea6635cda6c4c25a75a2df567347ee6
Autor:
Faizan Khan, Miriam Kimpton, Tobias Tritschler, Grégoire Le Gal, Brian Hutton, Dean A. Fergusson, Marc A. Rodger
Publikováno v:
Systematic Reviews, Vol 8, Iss 1, Pp 1-7 (2019)
Abstract Background The optimal duration of anticoagulation after a first unprovoked venous thromboembolism (VTE) remains controversial. Deciding to stop or continue anticoagulant therapy indefinitely after completing 3 to 6 months of initial treatme
Externí odkaz:
https://doaj.org/article/03569e57c44e44c8b0128ba6a927c833
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 14-16 (2021)
Externí odkaz:
https://doaj.org/article/58f93bebc5c14c6f987c9619cd139779
Autor:
Kristina Vrotniakaite-Bajerciene, Tobias Tritschler, Katarzyna Aleksandra Jalowiec, Helen Broughton, Justine Brodard, Naomi Azur Porret, Alan Haynes, Alicia Rovo, Johanna Anna Kremer Hovinga, Drahomir Aujesky, Anne Angelillo-Scherrer
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 14, p 4188 (2022)
(1) Background: Thrombophilia testing utility has remained controversial since its clinical introduction, because data on its influence on treatment decisions are limited. (2) Methods: We conducted a single-center retrospective cohort study of 3550 u
Externí odkaz:
https://doaj.org/article/a886d562d4a7452dbbbff58827ce2dcb
Autor:
Tobias Tritschler, Jacques D Donzé, Fabian D Liechti, Thomas Beck, Adrian Ruetsche, Marie C Roumet
Publikováno v:
BMJ Open, Vol 11, Iss 5 (2021)
Objective We aimed to develop and validate a score to assess inpatient complexity and compare its performance with two currently used but not validated tools to estimate complexity (ie, Charlson Comorbidity Index (CCI), patient clinical complexity le
Externí odkaz:
https://doaj.org/article/b713923c4d1543a19c865e4a389f0d69
Publikováno v:
European Journal of Internal Medicine. 109:131-134
Autor:
Lisa K. Moores, Tobias Tritschler, Shari Brosnahan, Marc Carrier, Jacob F. Collen, Kevin Doerschug, Aaron B. Holley, Jonathan Iaccarino, David Jimenez, Gregoire LeGal, Parth Rali, Philip Wells
Publikováno v:
Chest. 162:213-225
Autor:
Carla Schenker, Caterina E. Marx, Noémie Kraaijpoel, Grégoire Le Gal, Deborah M. Siegal, Frederikus A. Klok, Drahomir Aujesky, Tobias Tritschler
Publikováno v:
Journal of thrombosis and haemostasis, 21(6), 1553-1566. Wiley-Blackwell
Background: Fatal bleeding is a component of the primary safety outcome in most studies evaluating anticoagulation for venous thromboembolism (VTE), but a standardized definition for fatal bleeding is lacking. Objectives: To summarize definitions of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4294847d7d119d66c669d2a267493776
https://pure.amc.nl/en/publications/definitions-of-fatal-bleeding-in-clinical-studies-evaluating-anticoagulant-treatment-for-venous-thromboembolism(24cf9e49-6ade-4458-a47c-007dbfec7b1f).html
https://pure.amc.nl/en/publications/definitions-of-fatal-bleeding-in-clinical-studies-evaluating-anticoagulant-treatment-for-venous-thromboembolism(24cf9e49-6ade-4458-a47c-007dbfec7b1f).html